143 related articles for article (PubMed ID: 19298743)
1. ICSI outcome following conservative fertility sparing management of endometrial cancer.
Bozdag G; Yarali H; Polat M; Esinler I; Tiras B; Ayhan A
Reprod Biomed Online; 2009 Mar; 18(3):416-20. PubMed ID: 19298743
[TBL] [Abstract][Full Text] [Related]
2. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively.
Yarali H; Bozdag G; Aksu T; Ayhan A
Fertil Steril; 2004 Jan; 81(1):214-6. PubMed ID: 14711571
[TBL] [Abstract][Full Text] [Related]
3. Fertility-preserving treatment and pregnancy outcomes in the early stage of endometrial carcinoma.
Tong XM; Lin XN; Jiang HF; Jiang LY; Zhang SY; Liang FB
Chin Med J (Engl); 2013; 126(15):2965-71. PubMed ID: 23924476
[TBL] [Abstract][Full Text] [Related]
4. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer.
Demirol A; Bahce M; Ayhan A; Gurgan T
Reprod Biomed Online; 2005 Jun; 10(6):770-3. PubMed ID: 15970008
[TBL] [Abstract][Full Text] [Related]
6. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
8. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer.
Park JY; Seong SJ; Kim TJ; Kim JW; Bae DS; Nam JH
Gynecol Oncol; 2017 Jul; 146(1):39-43. PubMed ID: 28526167
[TBL] [Abstract][Full Text] [Related]
9. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L
Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012
[TBL] [Abstract][Full Text] [Related]
10. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
11. Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.
Kalogiannidis I; Agorastos T
J Obstet Gynaecol; 2011; 31(1):13-7. PubMed ID: 21280986
[TBL] [Abstract][Full Text] [Related]
12. Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection.
Shibahara H; Shigeta M; Toji H; Wakimoto E; Adachi S; Ogasawara T; Takemura T; Koyama K
Hum Reprod; 1999 Jul; 14(7):1908-11. PubMed ID: 10402416
[TBL] [Abstract][Full Text] [Related]
13. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Park JY; Nam JH
Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106
[TBL] [Abstract][Full Text] [Related]
14. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
Gong Q; Chen X; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic status in the offspring of spontaneous and assisted conception.
Whitelaw N; Bhattacharya S; Hoad G; Horgan GW; Hamilton M; Haggarty P
Hum Reprod; 2014 Jul; 29(7):1452-8. PubMed ID: 24812310
[TBL] [Abstract][Full Text] [Related]
17. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
Kudesia R; Singer T; Caputo TA; Holcomb KM; Kligman I; Rosenwaks Z; Gupta D
Am J Obstet Gynecol; 2014 Mar; 210(3):255.e1-4. PubMed ID: 24211482
[TBL] [Abstract][Full Text] [Related]
18. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
Yang HC; Liu JC; Liu FS
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Park JY; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH
Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
[TBL] [Abstract][Full Text] [Related]
20. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia.
Lowe MP; Cooper BC; Sood AK; Davis WA; Syrop CH; Sorosky JI
Gynecol Oncol; 2003 Dec; 91(3):569-72. PubMed ID: 14675678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
